Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoshuang Niu
Observed names:
X. Niu,
XiaoShuang Niu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0000-0001-6286-411X
Observed ORCID:
0000-0001-6286-411X
OpenAlex ID:
A5015017537
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials
2013
·
Lin Kong
, Chaosu Hu
, et al.
·
Cancer
·
66
Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma
2013
·
Xiaoshuang Niu
, Chaosu Hu
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
39
β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma
2016
·
Rui Jiang
, Xiaoshuang Niu
, et al.
·
Acta Biochimica et Biophysica Sinica
·
36
Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
2017
·
Ziyu Le
, Xiaoshuang Niu
, et al.
·
Oncotarget
·
28
PDF
Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue
2013
·
Xiaoshuang Niu
, Xi Chang
, et al.
·
Radiation Oncology
·
21
PDF
LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
2019
·
Chu Chu
, Xiaoshuang Niu
, et al.
·
OncoTargets and Therapy
·
20
PDF
Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era
2022
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
International Journal of Medical Sciences
·
19
PDF
Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer
2020
·
PeiYao Liu
, XiaoShuang Niu
, et al.
·
Frontiers in Oncology
·
17
PDF
Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
2021
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
Translational Oncology
·
14
PDF
Radiotherapy in the treatment of primary or recurrent unresectable desmoid tumors of the neck
2019
·
Xiaoshuang Niu
, Rui Jiang
, et al.
·
Cancer Investigation
·
13
EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene
2016
·
Yuxiang Huang
, Xuanyi Wang
, et al.
·
Molecular Carcinogenesis
·
13
Is postoperative radiotherapy an essential treatment for nonmetastatic lymphoepithelial carcinoma of the salivary gland?
2022
·
Xiaoshuang Niu
, Peiyao Liu
, et al.
·
Radiotherapy and Oncology
·
11
PDF
β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma
2016
·
Rui Jiang
, Xiaoshuang Niu
, et al.
·
Acta Biochimica et Biophysica Sinica
·
11
PDF
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study
2023
·
Xiaoshuang Niu
, Peiyao Liu
, et al.
·
Translational Oncology
·
10
Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
2021
·
Xin Zhou
, XiaoShuang Niu
, et al.
·
Frontiers in Immunology
·
9
PDF
Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study
2024
·
Rui Yang
, Ruichen Li
, et al.
·
Oral Oncology
·
5
Is nasopharyngeal carcinoma in young patients a distinct clinical entity? A single-institution case matched analysis in the era of intensity-modulated radiotherapy
2020
·
Dan Ou
, Xiaoshen Wang
, et al.
·
Oral Oncology
·
5
Radiation Plus Concurrent Nimotuzumab Versus Cisplatin-Based Chemotherapy in Locally Advanced Nasopharyngeal Cancer: An Interim Analysis of a Phase 3 Randomized Clinical Trial
2015
·
L. Kong
, Q. Lin
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
5
Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
2024
·
Yuming Zheng
, Fen Xue
, et al.
·
Cancer Medicine
·
4
PDF
Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
2025
·
Xiaoshuang Niu
, Fen Xue
, et al.
·
International Journal of Medical Sciences
·
3
PDF
Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland?
2023
·
Xiaoshuang Niu
, Peiyao Liu
, et al.
·
BMC Cancer
·
3
PDF
Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
2022
·
Fen Xue
, Xiaoshuang Niu
, et al.
·
Frontiers in Oncology
·
3
PDF
New Developments in the Management of Nasopharyngeal Carcinoma
2021
·
Xiaoshuang Niu
, Yungan Tao
·
Springer eBooks
·
3
PDF
Prognostic value of early Epstein-Barr Virus DNA response in patients with locoregionally advanced nasopharyngeal carcinoma
2026
·
Chengrun Du
, Ruiping Zhai
, et al.
·
Oral Oncology
·
2
Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults
2025
·
Yuming Zheng
, Fen Xue
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
2
Show more works
View as search
Works count:
33
Citation count:
367
H-index:
11
I10-index:
14
Year
Topic
Type